Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.4200 (0.28%) ($5.1900 - $6.0300) on Wed. Jul. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.6% (three month average) | RSI | 79 | Latest Price | $5.4200(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 11.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) MCHI(11%) FXI(10%) KWEB(10%) EEM(9%) VWO(9%) | Factors Impacting BCRX price | BCRX will decline at least -3.8% in a week (0% probabilities). VIXM(-4%) UUP(-4%) TLT(-4%) PCY(-4%) BND(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.8% (StdDev 7.6%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.14(5.45%) | 10 Day Moving Average | $4.9(10.61%) | 20 Day Moving Average | $4.58(18.34%) | To recent high | -3% | To recent low | 8.1% | Market Cap | $956m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |